A Game Changer In Healthcare
Transform Public Health - Regulator Scenario
Joan as the head of a recently formed task force to recommend regulatory reforms at a major federal agency has a very difficult task in front of her. There are multiple pressures that led to the formation of this task force:
Joan realizes that in order to simplify and expedite the regulatory review process, a higher level measure that is holistic and gives more consistent view of the patient is critical. She wishes there was a solution to this challenge.
Joan’s instincts are right. PHI (Φ) as a SINGLE measure of health and vitality for the Whole Person representing multiple factors and dimensions offers regulators an opportunity to measure the impact of a drug, therapy or a delivery system on the overall health and vitality of the patient rather than some narrowly defined outcomes for approval.
This would help simplify, and expedite the approval process, reduce potential for adverse effects of the therapies post launch, and with precision medicine, improve the health, vitality and productivity of the targeted populations and of the nation as a whole – the core mission of her agency.
PHI (Φ) Difference
Adaption of the PHI (Φ) based measurement of the Whole Person would dramatically effect research and development, testing, measurement, and approval of drugs, therapies and delivery systems for a vital, healthier and more productive nation with a less expensive healthcare system.
Expand outcome measures
Reduce adverse and negative outcomes
Make regulatory system transparent, visible, and measurable
Deliver effective and sustainable results
PHI (Φ) linked outcomes would provide more effective and sustainable therapies, drugs or devices for the Whole Person.
Promote Precision Medicine
Combining genetic markers with the PHI (Φ) model consisting of multiple dimensions and factors influencing the health, vitality and productivity of the Whole Person would deliver unprecedented insights and help develop precise solutions for the targeted populations.
Transform the regulatory regime
PHI (Φ) would help transform the way the effectiveness is measured, reviewed and approved toward a better, safer, and consistent consumer focused regulatory regime that promotes overall health, vitality, and productivity across the nation and the world.
© 2017 valueideas.
All rights reserved.